In This Section
Powering Precision Medicine

AACR Project GENIE is a publicly accessible international cancer registry of real-world data assembled through data sharing.

Learn More

Supporting the Complete Life Cycle of Research

As part of its mission to prevent and cure cancer, the American Association for Cancer Research fosters cancer and related biomedical science. By training emerging scientists; by creating communities around key disciplines; by funding promising projects; by convening thought leaders to overcome barriers to progress; by recognizing and celebrating key contributors to the field; and by collaborating with organizations around the world, the AACR supports the complete life cycle of cancer research.

Fellows of the AACR Academy

The AACR Academy was established in 2013 to recognize and honor distinguished scientists whose major contributions have propelled significant innovation and progress against cancer. These Fellows of the AACR Academy have been selected through a rigorous peer review process that evaluates individuals on the basis of their stellar scientific achievements in cancer research or cancer-related biomedical science.

Scientific Achievement Awards and Lectureships

Since 1961, the AACR has presented hundreds of prizes, awards, and lectureships recognizing the achievements of researchers and physician-scientists who have made significant contributions to the understanding, diagnosis, prevention, and treatment of cancer.

Meetings, Educational Workshops, and Special Courses

Collaboration and communication are the foundation of scientific inquiry, and these elements are at the heart of the AACR’s scientific meetings. With larger conferences that drive innovation in critical areas of the field to smaller meetings focused on emerging areas and specific disease sites, the AACR provides forums for dynamic interactions and exciting science. The AACR Annual Meeting is the largest of its kind in the world for cancer researchers.

AACR Educational Workshops and Special Courses provide early-career investigators with opportunities to develop skills in clinical trial design, molecular biology, drug development, translational research, and related fields. These programs enable individuals with some career experience to sharpen their skills, expand their expertise, and form collaborations among peers and leaders from around the world.


​The AACR publishes a portfolio of highly rated peer-reviewed journals that are among the most influential in cancer science and medicine. The entire portfolio of AACR journals, which represent just over 2 percent of the 313 journals in the oncology category, garnered about 13 percent of all citations in the same category, according to Journal Citation ReportsTM from Clarivate, 2021. One half of the AACR journals rank in the top 8 percent in regard to impact factor in the oncology category. The latest addition to the AACR journal portfolio is Cancer Research Communications, an open access journal covering the full breadth of the field.

Research Funding

The AACR funds research directly, as well as in cooperation with numerous cancer-focused organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer-reviewed grant administration and scientific oversight of team science and individual grants for cancer research projects that have the potential to improve patient outcomes.

Scientific Task Forces, Committees, and Working Groups

In addition to supporting the cancer research agenda, the AACR helps to define it by convening thought leaders in key disciplines. AACR committees identify scientific priorities in critical research areas, and AACR task forces address challenges and explore important questions to drive innovation in the field.

Recognizing the vital need for communication and collaboration, the AACR also establishes working groups around selected scientific disciplines. These communities provide a forum for diverse groups of scientists who share a common interest to exchange knowledge and forge working relationships that accelerate progress against cancer.